Coegin Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Coegin Pharma has a total shareholder equity of SEK21.6M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK22.5M and SEK894.0K respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 13.77m |
| Equity | SEK 21.59m |
| Total liabilities | SEK 894.00k |
| Total assets | SEK 22.48m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7Z6's short term assets (SEK14.8M) exceed its short term liabilities (SEK894.0K).
Long Term Liabilities: 7Z6 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 7Z6 is debt free.
Reducing Debt: 7Z6 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 7Z6 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 7Z6 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 5% each year